Recent Work
-
Blood‐Based Biomarkers for Alzheimer’s Pathology and the Diagnostic Process for a Disease‐Modifying Treatment: Projecting the Impact on the Cost and Wait Times
Blood‐based biomarker tests are a promising tool to improve triaging Alzheimer’s disease at the primary care level.
Categorized in